Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.

<h4>Background</h4>Pneumonia is a common and severe complication of abdominal surgery, it is associated with increased length of hospital stay, healthcare costs, and mortality. Further, pulmonary complication rates have risen during the SARS-CoV-2 pandemic. This study explored the potent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mwayi Kachapila, Adesoji O Ademuyiwa, Bruce M Biccard, Dhruva N Ghosh, James Glasbey, Mark Monahan, Rachel Moore, Dion G Morton, Raymond Oppong, Rupert Pearse, Tracy E Roberts, NIHR Global Health Research Unit on Global Surgery, ASOS Investigators, STARSurg Collaborative
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2a0a006881b94a1d890ea3fe6aaef264
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2a0a006881b94a1d890ea3fe6aaef264
record_format dspace
spelling oai:doaj.org-article:2a0a006881b94a1d890ea3fe6aaef2642021-11-25T05:54:13ZPreliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.1932-620310.1371/journal.pone.0254698https://doaj.org/article/2a0a006881b94a1d890ea3fe6aaef2642021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254698https://doaj.org/toc/1932-6203<h4>Background</h4>Pneumonia is a common and severe complication of abdominal surgery, it is associated with increased length of hospital stay, healthcare costs, and mortality. Further, pulmonary complication rates have risen during the SARS-CoV-2 pandemic. This study explored the potential cost-effectiveness of administering preoperative chlorhexidine mouthwash versus no-mouthwash at reducing postoperative pneumonia among abdominal surgery patients.<h4>Methods</h4>A decision analytic model taking the South African healthcare provider perspective was constructed to compare costs and benefits of mouthwash versus no-mouthwash-surgery at 30 days after abdominal surgery. We assumed two scenarios: (i) the absence of COVID-19; (ii) the presence of COVID-19. Input parameters were collected from published literature including prospective cohort studies and expert opinion. Effectiveness was measured as proportion of pneumonia patients. Deterministic and probabilistic sensitivity analyses were performed to assess the impact of parameter uncertainties. The results of the probabilistic sensitivity analysis were presented using cost-effectiveness planes and cost-effectiveness acceptability curves.<h4>Results</h4>In the absence of COVID-19, mouthwash had lower average costs compared to no-mouthwash-surgery, $3,675 (R 63,770) versus $3,958 (R 68,683), and lower proportion of pneumonia patients, 0.029 versus 0.042 (dominance of mouthwash intervention). In the presence of COVID-19, the increase in pneumonia rate due to COVID-19, made mouthwash more dominant as it was more beneficial to reduce pneumonia patients through administering mouthwash. The cost-effectiveness acceptability curves shown that mouthwash surgery is likely to be cost-effective between $0 (R0) and $15,000 (R 260,220) willingness to pay thresholds.<h4>Conclusions</h4>Both the absence and presence of SARS-CoV-2, mouthwash is likely to be cost saving intervention for reducing pneumonia after abdominal surgery. However, the available evidence for the effectiveness of mouthwash was extrapolated from cardiac surgery; there is now an urgent need for a robust clinical trial on the intervention on non-cardiac surgery.Mwayi KachapilaAdesoji O AdemuyiwaBruce M BiccardDhruva N GhoshJames GlasbeyMark MonahanRachel MooreDion G MortonRaymond OppongRupert PearseTracy E RobertsNIHR Global Health Research Unit on Global SurgeryASOS InvestigatorsSTARSurg CollaborativePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 8, p e0254698 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mwayi Kachapila
Adesoji O Ademuyiwa
Bruce M Biccard
Dhruva N Ghosh
James Glasbey
Mark Monahan
Rachel Moore
Dion G Morton
Raymond Oppong
Rupert Pearse
Tracy E Roberts
NIHR Global Health Research Unit on Global Surgery
ASOS Investigators
STARSurg Collaborative
Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
description <h4>Background</h4>Pneumonia is a common and severe complication of abdominal surgery, it is associated with increased length of hospital stay, healthcare costs, and mortality. Further, pulmonary complication rates have risen during the SARS-CoV-2 pandemic. This study explored the potential cost-effectiveness of administering preoperative chlorhexidine mouthwash versus no-mouthwash at reducing postoperative pneumonia among abdominal surgery patients.<h4>Methods</h4>A decision analytic model taking the South African healthcare provider perspective was constructed to compare costs and benefits of mouthwash versus no-mouthwash-surgery at 30 days after abdominal surgery. We assumed two scenarios: (i) the absence of COVID-19; (ii) the presence of COVID-19. Input parameters were collected from published literature including prospective cohort studies and expert opinion. Effectiveness was measured as proportion of pneumonia patients. Deterministic and probabilistic sensitivity analyses were performed to assess the impact of parameter uncertainties. The results of the probabilistic sensitivity analysis were presented using cost-effectiveness planes and cost-effectiveness acceptability curves.<h4>Results</h4>In the absence of COVID-19, mouthwash had lower average costs compared to no-mouthwash-surgery, $3,675 (R 63,770) versus $3,958 (R 68,683), and lower proportion of pneumonia patients, 0.029 versus 0.042 (dominance of mouthwash intervention). In the presence of COVID-19, the increase in pneumonia rate due to COVID-19, made mouthwash more dominant as it was more beneficial to reduce pneumonia patients through administering mouthwash. The cost-effectiveness acceptability curves shown that mouthwash surgery is likely to be cost-effective between $0 (R0) and $15,000 (R 260,220) willingness to pay thresholds.<h4>Conclusions</h4>Both the absence and presence of SARS-CoV-2, mouthwash is likely to be cost saving intervention for reducing pneumonia after abdominal surgery. However, the available evidence for the effectiveness of mouthwash was extrapolated from cardiac surgery; there is now an urgent need for a robust clinical trial on the intervention on non-cardiac surgery.
format article
author Mwayi Kachapila
Adesoji O Ademuyiwa
Bruce M Biccard
Dhruva N Ghosh
James Glasbey
Mark Monahan
Rachel Moore
Dion G Morton
Raymond Oppong
Rupert Pearse
Tracy E Roberts
NIHR Global Health Research Unit on Global Surgery
ASOS Investigators
STARSurg Collaborative
author_facet Mwayi Kachapila
Adesoji O Ademuyiwa
Bruce M Biccard
Dhruva N Ghosh
James Glasbey
Mark Monahan
Rachel Moore
Dion G Morton
Raymond Oppong
Rupert Pearse
Tracy E Roberts
NIHR Global Health Research Unit on Global Surgery
ASOS Investigators
STARSurg Collaborative
author_sort Mwayi Kachapila
title Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
title_short Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
title_full Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
title_fullStr Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
title_full_unstemmed Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
title_sort preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in south africa.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/2a0a006881b94a1d890ea3fe6aaef264
work_keys_str_mv AT mwayikachapila preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
AT adesojioademuyiwa preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
AT brucembiccard preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
AT dhruvanghosh preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
AT jamesglasbey preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
AT markmonahan preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
AT rachelmoore preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
AT diongmorton preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
AT raymondoppong preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
AT rupertpearse preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
AT tracyeroberts preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
AT nihrglobalhealthresearchunitonglobalsurgery preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
AT asosinvestigators preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
AT starsurgcollaborative preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica
_version_ 1718414389213659136